Cargando…
Effects of Verapamil and Diltiazem on the Pharmacokinetics and Pharmacodynamics of Rivaroxaban
Concomitant use of rivaroxaban with non-dihydropyridine calcium channel blockers (non-DHPs) might lead to an increase of systemic rivaroxaban exposure and anticoagulant effects in relation to the inhibition of metabolic enzymes and/or transporters by non-DHPs. This study was designed to evaluate the...
Autores principales: | Kim, Minsoo, Son, Heebin, Noh, Keumhan, Kim, Eunyoung, Shin, Beom Soo, Kang, Wonku |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470838/ https://www.ncbi.nlm.nih.gov/pubmed/30893910 http://dx.doi.org/10.3390/pharmaceutics11030133 |
Ejemplares similares
-
Stereo-Selective Pharmacokinetics of Ilimaquinone Epimers Extracted from a Marine Sponge in Rats
por: Son, Heebin, et al.
Publicado: (2019) -
Pharmacokinetics of Shikimic Acid Following Intragastric and Intravenous Administrations in Rats
por: Noh, Keumhan, et al.
Publicado: (2020) -
Pharmacokinetics of panduratin A following oral administration of a Boesenbergia pandurata extract to rats
por: Won, Jihyun, et al.
Publicado: (2021) -
Effects of Carbamazepine and Phenytoin on Pharmacokinetics and Pharmacodynamics of Rivaroxaban
por: Ngo, Lien Thi, et al.
Publicado: (2020) -
Effects of Itraconazole and Diltiazem on the Pharmacokinetics and Pharmacodynamics of Milvexian, A Factor XIa Inhibitor
por: Perera, Vidya, et al.
Publicado: (2022)